3

PRIMARY DOCUMENT

Company: ENANTA PHARMACEUTICALS INC
Filed: March 20, 2013
Period of Report: March 20, 2013
Accession Number: 0001012975-13-000119

View Document ↗ View on SEC.gov ↗